- Home
- ANVS vs LVO Comparison
ANVS vs LVO Comparison
Compare ANVS & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | LVO |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 65.9M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ANVS | LVO |
|---|---|---|
| Price | $1.75 | $4.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $13.50 | $11.50 |
| AVG Volume (30 Days) | ★ 991.0K | 68.7K |
| Earning Date | 05-12-2026 | 06-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 39.39 | ★ 78.57 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $77,144,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.54 | $0.43 |
| 52 Week High | $5.50 | $7.19 |
Technical Indicators
Market Signals| Indicator | ANVS | LVO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About LVO LiveOne Inc.
LiveOne Inc creator-first, music, entertainment and technology platform focused on delivering premium experiences and content world'wide through paid users and live and virtual events. It is in the acquisition, distribution and monetization of live music events, Internet radio, podcasting/vodcasting and music-related membership, streaming and video content. It provide services through a dedicated over-the-top application powered by Slacker (LiveOne App) called LiveOne. The company has three operating segments, PodcastOne, Slacker and Media Group. The company generates majority of revenue from PodcastOne. The Company's operations are based in the United States.